Project information 

  • Full title: PROPHET (PeRsOnalised Prevention roadmap for the future HEalThcare in Europe) 
  • Duration: 48 Months (1 September 2022 – 31 August 2026) 
  • Status: Ongoing 
  • Funding programme: PROPHET is funded by the European Commission under the Horizon Europe research and Innovation Programme, under Grant agreement ID: 101057721.  

What will the project do?  

  • PROPHET will engage organisations and individuals in order to contribute to building a Strategic Research Innovation Agenda to adopt Personalised Prevention approaches into EU health systems.  

What are the expected outcomes? 

  • PROPHET will deliver specific measures to educate and empower different stakeholder groups – citizens, healthcare professionals, and policy makers – to play an active role in the self-management of health and self-care. 
  • The project will build a Personalised Prevention Roadmap for the future healthcare, that will be co-created together with a large panel of stakeholders gathered in the PROPHET Stakeholder Forum. 
  • The Personalised Prevention Roadmap aims to support the definition and implementation of innovative, sustainable and high-quality personalised strategies that are effective in preventing chronic diseases. 

What is EPFs’ role? 

  • EPF’s participation in the project will centre around:  
  • mapping current practices and gaps in patient engagement in personalised prevention;  
  • capacity building activities for member organisations;  
  • and supporting the project’s impact and visibility with communications activities.  

Why does this matter for patients? 

  • Prevention is in fact a high priority at the European level: 900,000 people in EU countries die prematurely every year due to risk factors that can largely be prevented through a shift from the treatment of established diseases to a “person-centered” disease prevention and early diagnosis, where citizens and patients are equals and active partners in their care pathway. 

The consortium: 

  • The PROPHET project is a multidisciplinary group of 18 partner organizations from across 12 Countries working on the different dimensions of Personalized Prevention 
  • Partners include representatives from research organisations, healthcare organisations, patient and citizen associations, public authorities, scientific societies, and companies involved in innovative topics.  


  • Università Cattolica Del Sacro Cuore (coordinator)  
  • Foundation For Genomics & Population Health 
  • Consorcio Centro De Investigacion Biomedica En Red M.P. 
  • Stichting Vumc 
  • University Of Debrecen, University Of Tartu 
  • Universiteit Gent 
  • Katholieke Universiteit Leuven 
  • Karolinska Institutet 
  • Fondazione Policlinico Universitario Agostino Gemelli Irccs 
  • Instituto De Salud Carlos Iii 
  • Instituto Nacional De Saude Dr. Ricardo Jorge 
  • Finnish Institute for Health And Welfare 
  • Cittadinanzattiva APS 
  • European Patients Forum 
  • European Public Health Association 
  • European Molecular Biology Laboratory-ELIXIR and Biobanks And Biomolecular ResourcesResearch Infrastructure Consortium BBMRI-ERIC 
  • Allelica SRL 
  • G.A.C.